These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 35735984

  • 1. Activity of N-Acetylcysteine Alone and in Combination with Colistin against Pseudomonas aeruginosa Biofilms and Transcriptomic Response to N-Acetylcysteine Exposure.
    Valzano F, Boncompagni SR, Micieli M, Di Maggio T, Di Pilato V, Colombini L, Santoro F, Pozzi G, Rossolini GM, Pallecchi L.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0100622. PubMed ID: 35735984
    [Abstract] [Full Text] [Related]

  • 2. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
    Hengzhuang W, Green K, Pressler T, Skov M, Katzenstein TL, Wu X, Høiby N.
    Pediatr Pulmonol; 2019 May 31; 54(5):575-580. PubMed ID: 30803159
    [Abstract] [Full Text] [Related]

  • 3. In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
    Jun Y, Youn CK, Jo ER, Cho SI.
    Int J Pediatr Otorhinolaryngol; 2019 Nov 31; 126():109622. PubMed ID: 31404783
    [Abstract] [Full Text] [Related]

  • 4. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF, Powell LC, Jack AA, Powell K, Beck K, Florance H, Forton J, Rye PD, Dessen A, Hill KE, Thomas DW.
    Antimicrob Agents Chemother; 2017 Sep 31; 61(9):. PubMed ID: 28630204
    [Abstract] [Full Text] [Related]

  • 5. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A, Lajoie B, El Hage S, Baziard G, Roques C.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774
    [Abstract] [Full Text] [Related]

  • 6. In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms.
    Pollini S, Boncompagni S, Di Maggio T, Di Pilato V, Spanu T, Fiori B, Blasi F, Aliberti S, Sergio F, Rossolini GM, Pallecchi L.
    J Antimicrob Chemother; 2018 Sep 01; 73(9):2388-2395. PubMed ID: 29846610
    [Abstract] [Full Text] [Related]

  • 7. In Vitro Synergism of Colistin and N-acetylcysteine against Stenotrophomonas maltophilia.
    Ciacci N, Boncompagni S, Valzano F, Cariani L, Aliberti S, Blasi F, Pollini S, Rossolini GM, Pallecchi L.
    Antibiotics (Basel); 2019 Jul 25; 8(3):. PubMed ID: 31349560
    [Abstract] [Full Text] [Related]

  • 8. In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm.
    Gómez-Junyent J, Murillo O, Yu HH, Azad MAK, Wickremasinghe H, Rigo-Bonnin R, Benavent E, Ariza J, Li J.
    Int J Antimicrob Agents; 2021 Feb 25; 57(2):106246. PubMed ID: 33253904
    [Abstract] [Full Text] [Related]

  • 9. The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
    Law JP, Wood AJ, Friman VP.
    Microbiol Spectr; 2022 Dec 21; 10(6):e0184222. PubMed ID: 36453898
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis.
    Alhajj N, Yahya MFZR, O'Reilly NJ, Cathcart H.
    Eur J Pharm Sci; 2024 Jan 01; 192():106654. PubMed ID: 38013123
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL, Weiser R, Powell LC, Forton J, Mahenthiralingam E, Rye PD, Hill KE, Thomas DW, Pritchard MF.
    mSphere; 2021 Jan 20; 6(1):. PubMed ID: 33472983
    [Abstract] [Full Text] [Related]

  • 12. Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an Ex Vivo Pig Model of the Cystic Fibrosis Lung.
    Harrington NE, Littler JL, Harrison F.
    Appl Environ Microbiol; 2022 Feb 08; 88(3):e0178921. PubMed ID: 34878811
    [Abstract] [Full Text] [Related]

  • 13. Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Lababidi N, Ofosu Kissi E, Elgaher WAM, Sigal V, Haupenthal J, Schwarz BC, Hirsch AKH, Rades T, Schneider M.
    J Control Release; 2019 Nov 28; 314():62-71. PubMed ID: 31654686
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct 28; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 15. Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung.
    Dingemans J, Monsieurs P, Yu SH, Crabbé A, Förstner KU, Malfroot A, Cornelis P, Van Houdt R.
    mBio; 2016 Aug 02; 7(4):. PubMed ID: 27486191
    [Abstract] [Full Text] [Related]

  • 16. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.
    Di Bonaventura G, Lupetti V, Di Giulio A, Muzzi M, Piccirilli A, Cariani L, Pompilio A.
    Microbiol Spectr; 2023 Aug 17; 11(4):e0035223. PubMed ID: 37306577
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
    Pompilio A, Crocetta V, Pomponio S, Fiscarelli E, Di Bonaventura G.
    Diagn Microbiol Infect Dis; 2015 Aug 17; 82(4):318-25. PubMed ID: 26004353
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
    Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.
    PLoS One; 2018 Aug 17; 13(10):e0203941. PubMed ID: 30273348
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE, Sweeney E, Alav I, Allen F, Moat J, Harrison F.
    J Vis Exp; 2021 Jan 22; (167):. PubMed ID: 33554970
    [Abstract] [Full Text] [Related]

  • 20. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK, Paulin OKA, Hoyer D, Roberts KD, Ziogas J, Baker MA, Karas J, Li J, Velkov T.
    ACS Infect Dis; 2018 May 11; 4(5):646-655. PubMed ID: 29566483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.